Multiplexed FRET-FLIM Profiling of Immune Checkpoint Interactions Predicts Response to Atezolizumab in Urothelial Carcinoma
L. Camacho
C. Cacho-Navas
J. AguÌero
B. Batmunkh
J. Gracia
K. Sullivan
M. Rementeria
J. Miles
J. Gumuzio
F. Aguirre
S. Algarra
C. D. De Andrea
P. J. Parker
V. Calleja
Medicine